Table 1

Basic pharmacokinetic parameters for ALX-0081 after single IV administration to cynomolgus monkeys

Dose, mg/kgAUCinfd, h × kg/mLCL, mL/h/kgt1/2 terminal, h
0.02 0.559 ± 0.192 1.97 ± 0.65 17.0 ± 6.6 
0.40 0.085 ± 0.025 13.24 ± 6.11 18.9 ± 6.1 
8.00* 0.016 ± 0.004 65.69 ± 15.31 30.2 ± 5.3 
Dose, mg/kgAUCinfd, h × kg/mLCL, mL/h/kgt1/2 terminal, h
0.02 0.559 ± 0.192 1.97 ± 0.65 17.0 ± 6.6 
0.40 0.085 ± 0.025 13.24 ± 6.11 18.9 ± 6.1 
8.00* 0.016 ± 0.004 65.69 ± 15.31 30.2 ± 5.3 

Mean ± SD, n = 6 per dose level. Increase of CL with dose is an artifact of the noncompartmental analysis.

AUCinf indicates area under the plasma concentration time curve, calculated from 0 to infinity; D, dose; and CL, clearance.

*

One animal was considered an outlier due to a nondecreasing profile and was therefore excluded from the analysis (n = 5).

or Create an Account

Close Modal
Close Modal